Technology applied to diabetes

Technology applied to diabetes

At the 17th International Conference of ATTD 2024, the central topics were the diagnosis of type 1 diabetes in preclinical stages and the contributions of technology in type 2 diabetes. In addition, the role of artificial intelligence in new monitoring options.

Lic. María Fernanda Cristoforetti, Editor of Lugones Editorial

I. Carlson AL, et al. Flash glucose monitoring in type 2 patients managed with basal insulin in USA. BMJ Open Diabetes Res Care 2022;10(1):e002590.

II. Guerci B, et al. Important decrease in hospitalizations for acute diabetes events following FreeStyle Libre system initiation in people with type 2 diabetes on basal insulin therapy in France. Diabetes Technol Ther 2023 Jan;25(1):20-30.

III. Miller E, et al. FreeStyle Libre improves HbA1c in people receiving GLP-1 therapy for type 2 diabetes. ATTD Conference, March 6-9, 2024, Florence, Italy.

IV. Wright E, et al. Initiating GLP-1 therapy in combination with FreeStyle Libre provides greater benefit compared to GLP-1 alone. ATTD Conference, March 6-9, 2024, Florence, Italy.

V. Choe HG, et al. Effects of patient-driven lifestyle modification using intermittently scanned continuous glucose monitoring in patients with type 2 diabetes. Results from the randomized open-label PDF study. Diabetes Care 2022;45(10):2224-2230.